[HTML][HTML] Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura, M Al-Madol… - Journal of …, 2022 - Springer
Background Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.

SA Mousa, BI Khalefa, M Shaqura… - Journal of …, 2022 - europepmc.org
Background Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

[HTML][HTML] Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa… - Journal of …, 2022 - jneuroinflammation.biomedcentral …
Under inflammatory conditions, the activation of corticotropin-releasing factor (CRF) receptor
has been shown to inhibit pain through opioid peptide release from immune cells or …

[HTML][HTML] Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura… - Journal of …, 2022 - ncbi.nlm.nih.gov
Background Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

[PDF][PDF] Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura, M Al‑Madol… - 2022 - d-nb.info
Background: Under inflammatory conditions, the activation of corticotropin‑releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura… - Journal of …, 2022 - refubium.fu-berlin.de
Background: Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura… - Journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
Background Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SAMI Khalefa, M Shaqura, M Al-Madol… - Journal of …, 2022 - search.proquest.com
Background Under inflammatory conditions, the activation of corticotropin-releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

[PDF][PDF] Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas

SA Mousa, BI Khalefa, M Shaqura, M Al‑Madol… - 2022 - researchgate.net
Background: Under inflammatory conditions, the activation of corticotropin‑releasing factor
(CRF) receptor has been shown to inhibit pain through opioid peptide release from immune …

Superior control of inflammatory pain by corticotropin-releasing factor receptor 1 via opioid peptides in distinct pain-relevant brain areas.

SA Mousa, BI Khalefa, M Shaqura… - Journal of …, 2022 - search.ebscohost.com
Abstract < bold> Background: </bold> Under inflammatory conditions, the activation
of corticotropin-releasing factor (CRF) receptor has been shown to inhibit pain through …